Investigating the Increased Risk of Falls in Individuals With Parkinson's Disease Treated With Deep Brain Stimulation
Part of paid clinical trials in Homewood, Alabama.
- Sponsor
- University of Alabama at Birmingham
- Study ID
- NCT07725315
- Status
- Not Yet Recruiting
Notify me when recruiting opens
Save your spot on the interest list for this study. We'll keep your details with this study so our team can follow up when recruiting opens.
Add your contact details and location so we can keep your interest tied to this study.
Conditions
- Deep Brain Stimulation
- PARKINSON DISEASE (Disorder)
Eligibility Criteria
- Sex
- ALL
- Age
- 30 Years - 80 Years
- Healthy Volunteers
- Not accepted
Interventions
- DBS as part of standard of care — BEHAVIORALIndividuals with Parkinson's Disease will be selected to undergo DBS as part of standard of care. Those individuals will be assessed prior to and 3 months after.
Study Details
The purpose of this pilot study is to assess changes in thinking and movement after deep brain stimulator implantation. The study will also examine whether these changes are related to the risk of falls.
Key Dates
- First listed
- Jul 24, 2026
- Start date
- Aug 1, 2026
- Status verified
- Jul 2026
- Primary completion
- Nov 1, 2027
- Completion
- Nov 1, 2027
Study Design
- Enrollment
- 20 participants (estimated)
- Allocation
- NA
- Intervention model
- SINGLE_GROUP
- Primary purpose
- DIAGNOSTIC
Arms
- Experimental: DBS for standard of careIndividuals who undergo DBS surgery as part of standard of care will be observed prior to and after DBS surgery and data at these timepoints associated with indicine falls.
Primary Outcome Measure
Self-Reported Falls [ Time Frame: From enrollment to end of study will be 4-5 months ]
Central Contacts
- Christopher Hurt, PhD2059345817
Locations (1)
| Facility | City | State | ZIP | Site coordinators |
|---|---|---|---|---|
| UAB WHARF at Lakeshore | Homewood | Alabama | 35294 |
Find similar trials in Homewood, AL
By research site
Related Studies
- A Study of Buntanetap in Participants With PDPHASE2/PHASE3 · Recruiting · Annovis Bio Inc. · Birmingham, Alabama
- Using taVNS to Modulate Cardiovascular Function in Individuals With Neurologic DiseasePHASE1 · Recruiting · University of Alabama at Birmingham · Birmingham, Alabama
- Understanding Motivation in Parkinson's Patients Through NeurophysiologyRecruiting · University of California, San Francisco · San Francisco, California
- Use of CereGate Therapy for Freezing of Gait in PDRecruiting · CereGate Inc. · Redwood City, California